Virax Biolabs Group Ltd (VRAX) Payables (2021 - 2025)

Virax Biolabs' Payables history runs 5 years deep, the most recent figure standing at $56093.0 for Q1 2025.

• In Q1 2025, Payables rose 22.93% year-over-year to $56093.0; the TTM figure through Mar 2025 stood at $56093.0 (up 22.93% YoY), while the FY2025 annual figure was $56093.0, up 22.93% from the prior year.
• Payables was $56093.0 for Q1 2025 at Virax Biolabs, up from $45631.0 in the prior quarter.
• In the past five years, Payables ranged from a high of $846474.0 in Q1 2022 to a low of $45631.0 in Q1 2024.
• Historically, Payables has averaged $265050.2 across 5 years, with a median of $159908.0 in 2023.
• The sharpest annual moves came in 2022 and 2023: Payables surged 289.82% in 2022, then plunged 81.11% in 2023.
• A 5-year view of Payables shows it stood at $217145.0 in 2021, then soared by 289.82% to $846474.0 in 2022, then slumped by 81.11% to $159908.0 in 2023, then sank by 71.46% to $45631.0 in 2024, then gained by 22.93% to $56093.0 in 2025.
• The last three Payables figures came in at $56093.0 (Q1 2025), $45631.0 (Q1 2024), and $159908.0 (Q1 2023), per Business Quant data.